Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  ductal breast carcinoma
Stage/Subtype:  ductal breast carcinoma
Country:  U.S.A.
Trial Type:  Treatment
Results 1-25 of 27 for your search:
Start Over
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
Phase: Phase IV
Type: Treatment
Age: 40 and over
Trial IDs: CTPR-0009, NCI-2013-01601, NCT01644669
Metformin Hydrochloride in Preventing Breast Cancer in Patients with Atypical Hyperplasia or In Situ Breast Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Age: 25 to 55
Trial IDs: A211102, NCI-2013-00995, CALGB-A211102, NCT01905046
Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer
Phase: Phase II, Phase I
Type: Treatment
Age: 50 and over
Trial IDs: 201401160, NCI-2014-00269, NCT02076074
Accelerated Whole Breast Radiotherapy in Treating Patients with Breast Cancer Who Have Undergone Surgery
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 040807, NCI-2012-00535, CDR0000643276, CINJ-040807, NCT00909909
PD 0332991 in Treating Patients With Refractory Solid Tumors
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: UPCC 03909, NCI-2009-01467, NCT01037790
Laboratory Treated T Cells after Chemotherapy in Treating Patients with HER2-Negative Stage II-III Breast Cancer That Can Be Removed by Surgery
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2010-056, NCI-2011-02634, 1005008403, CDR0000675211, NCT01658969, WSU-2010-056, NCT01147016
Radiation Therapy in Treating Patients With Breast Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2009-0818, NCI-2011-01102, NCT01245712
Letrozole in Treating Postmenopausal Women with Ductal Carcinoma in Situ
Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Age: 18 and over
Trial IDs: CALGB 40903, NCI-2011-03452, CDR0000701992, NCT01439711
Accelerated Radiation Therapy after Surgery in Treating Patients with Breast Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 041001, NCI-2011-01124, NCT01417286
Radiation Therapy in Treating Post-Menopausal Women with Early Stage Breast Cancer Undergoing Surgery
Phase: Phase II
Type: Treatment
Age: 50 and over
Trial IDs: I 108907, NCI-2009-01568, NCT01754519
Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients with ERBB2 Expressing Disseminated Tumor Cells
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 201309084, NCI-2012-03110, 12-X356, NCT01779050
Accelerated Partial Breast Proton Radiation Therapy in Treating Patients with Stage IA-IIA Breast Cancer
Phase: Phase II
Type: Treatment
Age: 50 and over
Trial IDs: UPCC 04113, NCI-2013-00861, 817359, NCT01839838
Omega-3 Fatty Acid in Treating Patients with Stage I-III Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CCCWFU 98113, NCI-2013-00963, NCT01869764
Stereotactic Radiosurgery in Treating Patients with Early Stage Breast Cancer
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: TX011, NCI-2013-00785, SCCC-02110, STU 072010-01, NCT01162200
BYL719 and Letrozole With or Without Trastuzumab in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: VICC BRE 12101, NCI-2013-00102, CBYL719XUS03T, SU2C B07, NCT01791478
High Dose Rate Brachytherapy in Treating Patients with Endometrial, Cervical, Lung, Breast, or Prostate Cancer
Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Age: 18 to 90
Trial IDs: 09-C-0100, NCI-2013-01448, 090100, P08407, NCT00924027
3-Dimensional Conformal Accelerated Partial Breast Irradiation Before Surgery in Treating Patients With Stage I-IIA Breast Cancer
Phase: No phase specified
Type: Treatment
Age: 45 and over
Trial IDs: 0919GCC, NCI-2011-00570, NCT01014715
Radiofrequency Ablation After Breast Lumpectomy in Treating Patients With Breast Cancer
Phase: No phase specified
Type: Treatment
Age: 50 and over
Trial IDs: AAAF3783, NCI-2011-00746, NCT01153035
Pasireotide in Preventing the Spread of Breast Cancer in Patients with Non-Invasive Breast Cancer
Phase: No phase specified
Type: Treatment
Age: 21 and over
Trial IDs: NYU10-00641, NCI-2011-02367, BC097854, i10-00641, R10-00641, NCT01372618
Black Cohosh in Treating Patients with Breast Ductal Carcinoma in Situ
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 1205010204, NCI-2015-00920, NCT01628536
Image-Guided Accelerated Partial Breast Irradiation in Treating Patients With Stage 0-I Breast Cancer
Phase: No phase specified
Type: Treatment
Age: 50 and over
Trial IDs: HIC 1110009173, NCI-2013-00892, NCT01646346
Broccoli Sprout Extract in Treating Patients with Breast Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 21 and over
Trial IDs: I 211911, NCI-2012-01770, NCT01753908
Caloric Restriction in Treating Patients with Early Stage Breast Cancer Undergoing Surgery and Radiation Therapy
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: 12G.616, NCI-2013-00611, 2012-94, NCT01819233
Study to Assess Perfusion and Patient Satisfaction in Nipple-Areola Mastectomy With Immediate Reconstruction
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 201302004, NCI-2014-00013, NCT01969448
Start Over